[Immunomodulating effects of oral administration of PSK. II. Its effects on mice with cecal tumors].
D000276:Adjuvants, Immunologic; D000284:Administration, Oral; D000818:Animals; D002430:Cecal Neoplasms / Q000276:immunology* / Q000473:pathology / Q000628:therapy; D007694:Killer Cells, Natural / Q000276:immunology; D008213:Lymphocyte Activation; D051379:Mice; D011509:Proteoglycans / Q000008:administration & dosage / Q000627:therapeutic use*; D005641:Tegafur / Q000008:administration & dosage / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D011509:Proteoglycans; D005641:Tegafur; C010770:polysaccharide-K